Skip to content

Optimisation strategies based on driving pressure-mediated lung protection in robotic Assisted Laparoscopic Urology Surgery in Patients with Trendelenburg Position

Driving pressure-mediated lung protection based optimisation strategy in patients with Trendelenburg position in robot-assisted laparoscopic Urology surgery: a single-centre, clinically randomised controlled trial

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2400081690
Enrollment
Unknown
Registered
2024-03-08
Start date
2024-03-15
Completion date
Unknown
Last updated
2024-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Robot-assisted laparoscopic urology surgery

Interventions

individual PEEP group:After the Trendelenburg position and pneumoperitoneum were established, PEEP was started at PEEP = 5 cmH2O and then increased to 15 cmH2O at 1 cmH2O intervals, and five respirato
Individual PEEP combined with ultrasound lung RM group:After the Trendelenburg position and pneumoperitoneum were established, the procedure was started with PEEP = 5 cmH2O and then ramped up to 15 cm
Conventional Lung Protection Group:After the Trendelenburg position and pneumoperitoneum were established with PEEP = 5 cmH2O, lung RM was performed every hour after the start of the procedure and aga

Sponsors

Department of Anesthesiology, Chongqing University Cancer Hospital/ Chongqing Cancer Institute/ Chongqing Cancer Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. patients undergoing elective robotic-assisted laparoscopic urology surgery Trendelenburg position; 2. age =18 years; 3. signed informed consent; 4. operative time =2 hours.

Exclusion criteria

Exclusion criteria: 1. patients with severe cardiopulmonary diseases including but not limited to coronary artery disease, COPD, asthma exacerbation period, etc.; 2. patients with large pulmonary alveoli/pneumothorax; 3. patients with previous lung surgery; 4. intraoperative mid-operative conversion to open abdomen; 5. intraoperative haemorrhagic shock, anaphylactic reaction, malignant arrhythmia, and other adverse events; 6. patients refused to participate in the clinical trial.

Design outcomes

Primary

MeasureTime frame
Pulmonary complications within 7 days of surgery;

Secondary

MeasureTime frame
Intraoperative peak airway pressure; Intraoperative plateau pressure ; Intraoperative PaO2/FiO2 after initiation of Trendelenburg position and establishment of artificial pneumoperitoneum;Intraoperative mechanical power;Intraoperative dynamic lung compliance;Extubation time;average length of stay;Postoperative PaO2/FiO2 ;PEEP levels after individualized PEEP settings;

Countries

China

Contacts

Public ContactRan An

Chongqing University Cancer Hospital

anran1011@163.com+86 188 7527 8836

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026